Impact of ENVI vote on advanced therapies on medical technology industry
This article was originally published in Clinica
Executive Summary
It is likely to take another couple of weeks before the consolidated version of the amendments agreed on January 30 by the European Parliament's committee on the environment, public health and food safety (ENVI), on the European Commission's proposed Advanced Therapy Medicinal Products (ATMP) regulation, are made available.